Journal of Affective Disorders
Volume 117, Issue 3 , Pages 186-192 , October 2009

Affective temperaments in heroin addiction

  • Icro Maremmani

      Affiliations

    • “Vincent P. Dole” Dual Diagnosis Unit, Santa Chiara University Hospital, Department of Psychiatry, NPB, University of Pisa, Italy
    • AU-CNS, “From Science to Public Policy” Association, Pietrasanta, Lucca, Italy
    • “G. De Lisio”, Institute of Behavioural Sciences Pisa, Italy
    • Corresponding Author InformationCorresponding author. Vincent P. Dole, Dual Diagnosis Unit, Santa Chiara University Hospital, Department of Psychiatry, University of Pisa, Via Roma, 67 56100 Pisa, Italy. Tel.: +39 0584 790073; fax: +39 0584 72081.
  • ,
  • Matteo Pacini

      Affiliations

    • “G. De Lisio”, Institute of Behavioural Sciences Pisa, Italy
  • ,
  • Dina Popovic

      Affiliations

    • “Vincent P. Dole” Dual Diagnosis Unit, Santa Chiara University Hospital, Department of Psychiatry, NPB, University of Pisa, Italy
  • ,
  • Anna Romano

      Affiliations

    • “Vincent P. Dole” Dual Diagnosis Unit, Santa Chiara University Hospital, Department of Psychiatry, NPB, University of Pisa, Italy
  • ,
  • Angelo G.I. Maremmani

      Affiliations

    • AU-CNS, “From Science to Public Policy” Association, Pietrasanta, Lucca, Italy
    • Medical School, University of Pisa, Italy
  • ,
  • Giulio Perugi

      Affiliations

    • “Vincent P. Dole” Dual Diagnosis Unit, Santa Chiara University Hospital, Department of Psychiatry, NPB, University of Pisa, Italy
    • “G. De Lisio”, Institute of Behavioural Sciences Pisa, Italy
  • ,
  • Joseph Deltito

      Affiliations

    • “G. De Lisio”, Institute of Behavioural Sciences Pisa, Italy
    • Department of Psychiatry and Behavioural Science, New York Medical College, Valhalla, New York, USA
  • ,
  • Kareen Akiskal

      Affiliations

    • Union Nationale des Dépressifs et Maniaco-Dépressifs, Rouen, France
    • International Mood Centre, La Jolla, California, USA
  • ,
  • Hagop Akiskal

      Affiliations

    • Union Nationale des Dépressifs et Maniaco-Dépressifs, Rouen, France
    • International Mood Centre, La Jolla, California, USA
    • University of California at San Diego and Veterans Administration Hospital, San Diego, California, USA

Received 24 November 2008 ,Revised 8 January 2009 ,Accepted 8 January 2009.

References 

  1. A.P.A. . Diagnostic and Statistical Manual for Mental Disorders. Washington, DC: American Psychiatric Association; 1952;
  2. A.P.A. . DSM-III Diagnostic and Statistical Manual. 3d ed.. Washington,D.C.: American Psychiatric Association; 1980;
  3. Akiskal HS. The temperamental borders of affective disorders. Acta Psychiatr. Scand. 1994;89(suppl 379):32–37
  4. Akiskal HS. Developmental pathways to bipolarity: are juvenile-onset depressions pre-bipolar?. J. Am. Acad. Child Adolesc. Psych. 1995;34:754–763
  5. In:  Akiskal HS,  Akiskal KK editor. TEMPS: Temperament Evaluation of Memphis, Pisa, Paris and San Diego. J Affect Disord. vol. 85:2005;p. 1–242Special issue
  6. Akiskal KK, Akiskal HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J. Affect. Disord. 2005;85:231–239
  7. Akiskal HS, Mallya G. Criteria for the ‘soft’ bipolar spectrum: treatment implications. Psychopharmacol. Bull. 1987;23:68–73
  8. Akiskal HS, Djenderedjian AM, Rosenthal RH. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am. J. Psychiatry. 1977;134:1227–1233
  9. Akiskal HS, Down S, Jordan I, et al. Affective Disorders in referred children and younger siblings on manic depressives: mode of onset and prospective course. Arch. Gen. Psychiatry. 1985;42:996–1003
  10. Akiskal HS, Placidi GF, Maremmani I, et al. TEMPS-I: delineating the most discriminant traits of the cyclothymic, depressive, hyperthymic and irritable temperaments in a nonpatient population. J. Affect. Disord. 1998;51:7–19
  11. Akiskal HS, Hantouche EG, Allilaire JF. Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J. Affect. Disord. 2003;73:49–57
  12. Akiskal HS, Akiskal KK, Haykal RF, et al. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J. Affect. Disord. 2005;85:3–16
  13. Arntz A, Merckelbach H, De Jong P. Opioid antagonist affects behavioral effects of exposure in vivo. J. Consult. Clin. Psychol. 1993;61:865–870
  14. Benjamin JLL, Patterson C, Greenberg BD, et al. Population and familiar association between D4 dopamine receptor gene and measures of NS. Nat. Genet. 1996;12:81–84
  15. Bertelsen A, Haovald B, Hauge M. A Danish twin study of manic–depressive disorders. Br. J. Psychiatry. 1977;130:330–351
  16. Block J, Block JH, Keyes S. Longitudinally foretelling drug usage in adolescence: early childhood personality and environmental precursors. Child Dev. 1988;59:336–355
  17. Bouchard TJ, Lykken DT, McGue M, et al. Sources of human psychological differences: the Minnesota Study of Twins Reared Apart. Science. 1990;250:223–228
  18. Burger GK, Collins HA. Relationship between MMPI and CPI Types of Male Heroin Abusers. Am. J. Drug Alcohol Abuse. 1982;9:281–287
  19. Clerici M, Carta I, Cazzullo CL. Substance Abuse and Psychopathology: a diagnostic screening of Italian narcotic addicts. Soc. Psychiatry. 1989;24:219–226
  20. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch. Gen. Psychiatry. 1987;44:573–588
  21. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol. Rep. 1991;69:1047–1057
  22. Craig RJ. Personality characteristics of heroin addicts: a review of the empirical literature with critique — Part II. Int. J. Addict. 1979;14:607–626
  23. Depue RA, Slater JF, Wolfsetter-Kausch H. A behavioral paradigm for identifying persons at risk for bipolar disorder: a conceptual framework and five validation studies. J. Abnorm. Psychology. 1981;90:381–437
  24. Dorus W, Senay EC. Depression demographic dimensions, and drug abuse. Am. J. Psychiatry. 1980;137:669–704
  25. Esbaugh DM, Dick KV, Tori DJ. Typological analysis of MMPI personality patterns of drug dependent females. J. Pers. 1982;46:488–494
  26. Evans LM, Akiskal HS, Greenwood TA, et al. Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147:326–332
  27. Extein I, Pottash ALC, Gold MS. A possible opioid receptor dysfunction in some depressive disorders. Ann. N.Y. Acad. Sci. 1982;398:113–119
  28. Eysenck HJ, Eysenck SBJ. Manual of the Eysenck Personality Questionnaire. San Diego: Educational and Industrial Testing Service; 1975;
  29. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Arlington, VA, USA: American Psychiatric Publishing, Inc; 1997;
  30. Gerra G, Zaimovic A, Timpano M, et al. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 2000;25:479–496
  31. Haddox V, Jacobson M. Psychological adjustment, mood and personality fluctuations in long term methadone maintenance patients. Int. J. Addict. 1972;7:619–627
  32. Jacobs PE, Doft EB, Koger J. A study of SCL-90 scores of 264 methadone patients in treatment. Int. J. Addict. 1981;16:541–548
  33. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts: recent findings. Arch. Gen. Psychiatry. 1985;42:1067–1077
  34. Korin H. Comparison of psychometric measures in psychiatric patients using heroin and other drugs. J. Abnorm. Psychology. 1974;83:208–212
  35. Kosten TR, Rounsaville J, Kleber HB. DSM III Personality Disorders in opiate addicts. Compr. Psychiatry. 1982;23:572–581
  36. Kurtines W, Hogan R, Weiss DG. Personality dynamic of heroin use. J. Abnorm. Psychology. 1975;84:87–89
  37. Liraud F, Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders?. Psychiatry Res. 2000;93:63–72
  38. Maremmani I, Castrogiovanni P. DAH-RS: Drug Addiction History Rating Scale. Pisa: University Press; 1989;
  39. Maremmani I, Capone MR, Aglietti M, et al. Heroin dependence and Bipolar Disorders. New Trends Exp. Clin. Psychiatry. 1994;X:179–182
  40. Maremmani I, Akiskal HS, Signoretta S, et al. The relationship of Kraepelian affective temperaments (as measured by TEMPS-I) to the tridimensional personality questionnaire (TPQ). J. Affect. Disord. 2005;85:17–27
  41. Maremmani I, Pacini M, Pani PP, et al. The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a “dual diagnosis?”. Ann. Gen. Psychiatry. 2007;6:31
  42. Maremmani I, Pani PP, Canoniero S, et al. Is the Bipolar Spectrum the psychopathologic substrate of suicidality in heroin addicts?. Psychopathology. 2007;40:269–277
  43. Maremmani I, Pacini M, Perugi G, et al. Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposal of a pathophysiologic model. J. Affect. Disord. 2008;106:55–61
  44. Martin J, Ingles J. Pain tolerance and narcotic addiction. Br. J. Soc. Psychol. 1965;4:224–229
  45. Mason BJ, Kocsis JH, Melia D, et al. Psychiatric comorbidity in methadone maintained patients. J. Addict. Dis. 1998;17:75–89
  46. McLellan AT, Woody GE, O'Brien CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N. Engl. J. Med. 1979;301:1310–1314
  47. Mezzich JE, Ahn CW, Fabrega H. Patterns of psychiatric comorbidity in a large population presenting for care. In:  Maser JD,  Cloninger CR editor. Comorbidity of Mood and Anxiety disorders. Washington: American Psychiatric Press; 1990;
  48. Nace EP. Personality disorder in the alcoholic patient. Psychiatr. Ann. 1990;19:256–260
  49. Nisle A, Robinowitz R, Penk JR. An Empirical Test of Anhedonia in Compulsive Use of Illicit Drugs. Dallas, Texas: VAMC, Drug Abuse Program; 1979;
  50. Nunes EV, Quitkin FM, Klein DF. Psychiatric diagnosis in cocaine abuse. Psychiatry Res. 1989;28:105–114
  51. Penk WE. Assessing the substance abuser with the MMPI. Clinical notes on the MMPI. 1981;Hoffmann-La Roche, La Roche, Nutley
  52. Penk WE, Robinowitz R. Personality differences of heroin addicts and polydrug abusers. In:  Craig R,  Baker S editor. Drug dependent patients: treatment and research. Springfield: Charles Thomas; 1982;p. 187–219
  53. Penk WE, Robinowitz R, Woodward WA, et al. MMPI factor scale differences among heroin addicts differing in race and admission status. Int. J. Addict. 1980;15:329–337
  54. Penk WE, Robinowitz R, Roberts M. MMPI difference of male Hispanic–American, black and white heroin addicts. J. Consult. Clin. Psychol. 1981;49:488–490
  55. Platt JJ, Scurra W. Peer adjustment of parole success in institutionalized heroin addicts: personality correlates and validity. J. Consult. Clin. Psychol. 1975;21:511–515
  56. Reid WH. The Psychopathology: A Comprehensive Study of Antisocial Disorders and Behavior. New York: Wiley; 1978;
  57. Roehric H, Gold MS. Diagnosis of substance abuse in an adolescent psychiatric population. Int. J. Psychiatry Med. 1986;16/2:137–143
  58. Rothaizer JM. Typological study of substance abusers using the MMPI. J. Clin. Psychol. 1980;36:1019–1021
  59. Shaw BF, Steer RA, Beck AT, et al. Structure of depression in heroin addicts. Br. J. Addict. 1979;74:295–303
  60. Skodol AE, Oldham JM, Gallagher PE. Axis II comorbidity of substance abuse disorders among patients referred for treatment of personality disorders. Am. J. Psychiatry. 1999;156:733–738
  61. Steer RA, Schut J. Affect dimension of male heroin addicts admitted for inpatient detoxification. Int. J. Addict. 1981;1:341–348
  62. Teesson M, Havard A, Fairbairn S, et al. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend. 2005;78:309–315
  63. Vazquez GH, Kahn C, Schiavo CE, et al. Bipolar disorders and affective temperaments: a national family study testing the “endophenotype” and “subaffective” theses using the TEMPS-A Buenos Aires. J. Affect. Disord. 2008;108:25–32
  64. Verebey KE. Opioids in mental illness: theories, clinical observations and treatment possibilities. Ann. N.Y. Acad. Sci. 1982;398:
  65. Woody GE, O'Brien CP, Rickels K. Depression and anxiety in heroin addicts: a placebo controlled study of doxepin in combination with methadone. Am. J. Psychiatry. 1975;132:447–450
  66. Zimmerman M, Coryell W. DSM III Personality Disorders Diagnosis in a non patient sample: demographic correlates and comorbidity. Arch. Gen. Psychiatry. 1989;46:682–689
  67. Zuckerman M, Neeb M. Sensation seeking and psychopathology. Psychiatry Res. 1979;1:255–264
  68. Zuckermann M. Sensation Seeking: Beyond the Optimal Level of Arousal. Helesdale, N.J.: Erlboum; 1979;
  69. Zuckermann M. Sensation seeking, risk taking and health. In:  Janisse MP editors. Individual differences, stress and health. New York, NY: Springer-Verlag; 1988;p. 72–88

PII: S0165-0327(09)00028-7

doi: 10.1016/j.jad.2009.01.007

Journal of Affective Disorders
Volume 117, Issue 3 , Pages 186-192 , October 2009